How could we support you?

We offer expert advice, consultancy, training, and coaching for analytical development and (bio)pharmaceutical analysis. Explore our Brochure.

Our specialities:

• (Bio)pharmaceutical Analysis

• Method Development and Validation

• Quality Control

• Analytical Procedure Control Strategy

Analytical Quality by Design (AQbD)

• ICH Q14 and ICH Q2(R2)

Capillary Electrophoresis (CE)

• Troubleshooting

Analytical Experts

Kantisto BV is a specialised scientific consultancy focused on (bio)pharmaceutical analysis and Analytical Quality by Design (AQbD). We provide expert advice, consultancy, training, and coaching to enhance analytical development and quality control. Our expertise includes method development and validation, analytical control strategies, troubleshooting, and regulatory alignment with ICH Q14 and ICH Q2(R2).
With decades of combined academic and industry experience, Kantisto offers pragmatic, personalised support to help clients design, implement, and maintain robust analytical methods across all stages of (bio)pharmaceutical development.

Through the menu on the left you can find suggestions for consultancy projects or courses and trainings.
In the agenda you will find all public activities that are open for registration. For in-company or closed activities, or if the training course of your choice is not in the list, please contact Kantisto through the contact form.
Based in the Netherlands, Kantisto offers both long and short term services in Europe and throughout the world. 


About us

Prof. Dr. Cari E. Sänger – van de Griend is an expert in (bio)pharmaceutical analytical chemistry with 30 years of industrial and academic experience in method development and control strategies, including Analytical Quality by Design (AQbD), and focused on best practices and knowledge sharing. 

Dr. Ewoud van Tricht is an expert in (bio)pharmaceutical analysis with over 18 years of industrial experience in analytical development, Quality Control, and Analytical Quality by Design (AQbD). He has contributed to diverse therapeutic modalities, including small molecules, viruses, and cells, at leading companies such as Janssen Vaccines and Sanofi Cell Therapy.

For more information, click here: About Kantisto


Highlights

        New Image        

 

                 

 

                 

 

What our customers say

We are showcasing three pieces of feedback from our customers. For more feedback, click here: Feedback.